<DOC>
	<DOCNO>NCT01397461</DOCNO>
	<brief_summary>This multicenter , randomise , placebo control , parallel , blind ( double-blind ozenoxacin versus placebo comparison investigator blind retapamulin versus placebo comparison ) , superiority clinical study compare ozenoxacin cream versus placebo retapamulin ointment v placebo , patient clinical diagnosis non-bullous bullous impetigo .</brief_summary>
	<brief_title>Efficacy Safety Ozenoxacin 1 % Cream Versus Placebo Treatment Patients With Impetigo</brief_title>
	<detailed_description />
	<mesh_term>Impetigo</mesh_term>
	<criteria>Clinical diagnosis bullous non bullous impetigo . The patient total affect area comprised 1100 cm2 surround erythema extend 2 cm edge affect area . In case multiple affect area total area sum affect area exceed 100 cm2 . Additionally patient &lt; 12 year total area exceed maximum 2 % body surface area . Total Skin Infection Rating Scale ( SIRS ) score least 8 , include pus/exudate score least 1 Has bacterial infection , opinion investigator , could appropriately treated topical antibiotic . Has systemic sign symptom infection ( e.g . fever ; define axillary temperature 37.2 °C ( 99.0 °F )</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>